In Silico Study, Protein Kinase Inhibition and Molecular Docking Study of Benzimidazole Derivatives

被引:0
|
作者
Karthick, Kamaraj [1 ]
Abishek, Kamaraj [2 ]
Jemima, Ebenezer Angel [3 ]
机构
[1] Rajalakshmi Inst Technol, Dept Chem, Chennai 600124, Tamil Nadu, India
[2] Sadakathullah Appa Coll, Dept Zool, Tirunelveli, Tamil Nadu, India
[3] Trichy Res Inst Biotechnol Pvt Ltd, Trichy, India
来源
BIOINFORMATICS AND BIOLOGY INSIGHTS | 2024年 / 18卷
关键词
Benzimidazole derivatives; in silico study; protein kinase and molecular docking; ANTICANCER; MORTALITY; AGENTS;
D O I
10.1177/11779322241247635
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Kinase enzymes play an important role in cellular proliferation, and inhibition of their activity is a major goal of cancer therapy. Protein kinase inhibitors as benzimidazole derivatives can be applied for prevention or treatment of cancers through inhibition of cell proliferation. To evaluate their protein kinase inhibitory effects, as well as the in silico study for active benzimidazole derivatives. Benzimidazole derivatives has presented significant therapeutic potential against several disorders and known to have numerous biological activities (such as antibacterial, antiviral and anti-inflammatory). Benzimidazole derivatives have shown significant potential in the reduction of viral load as well as in enhancing immunity. To forecast absorption, distribution, metabolism, excretion and toxicity, simply known as ADMET and the Lipinski rule of five parameters of the examined substances, the admetSAR and Swiss ADME were used. The ADMET predictions revealed that the compounds had good and safe pharmacokinetic features, making them acceptable for further development as therapeutic candidates in clinical trials. This study primarily focused on blocking 2 key targets of kinase proteins (CDK4/CycD1 and Aurora B). 2-Phenylbenzimidazole has shown the greatest inhibitory potential (with a binding energy of -8.2 kcal/mol) against protein kinase inhibitors. This study results would pave the potential lead medication for anticancer therapeutic strategies.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Design, synthesis, α-amylase inhibition and in silico docking study of novel quinoline bearing proline derivatives
    Ganesan, M. S.
    Raja, K. Kanmani
    Narasimhan, K.
    Murugesan, S.
    Kumar, Banoth Karan
    JOURNAL OF MOLECULAR STRUCTURE, 2020, 1208
  • [32] Molecular docking study of the acetylcholinesterase inhibition
    Merzoug, Amina
    Boucherit, Hanane
    Khaled, Rima
    Chefiri, Amel
    Chikhi, Abdelouahab
    Bensegueni, Abderrahmane
    CURRENT ISSUES IN PHARMACY AND MEDICAL SCIENCES, 2021, 34 (01) : 20 - 27
  • [33] Synthesis, molecular docking and Brugia malayi thymidylate kinase (BmTMK) enzyme inhibition study of novel derivatives of [6]-shogaol
    Singh, Vinay Kr
    Doharey, Pawan K.
    Kumar, Vikash
    Saxena, J. K.
    Siddiqi, M. I.
    Rathaur, Sushma
    Narender, Tadigoppula
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 93 : 74 - 82
  • [34] Synthesis, thymidine phosphorylase, angiogenic inhibition and molecular docking study of isoquinoline derivatives
    Zaman, Khalid
    Rahim, Fazal
    Taha, Muhammad
    Wadood, Abdul
    Shah, Syed Adnan Ali
    Gollapalli, Mohammed
    Ullah, Farhat
    Ahmed, Ashfaq
    BIOORGANIC CHEMISTRY, 2019, 89
  • [35] Lipoxygenase Inhibition Activity of Coumarin Derivatives-QSAR and Molecular Docking Study
    Loncaric, Melita
    Strelec, Ivica
    Pavic, Valentina
    Subaric, Domagoj
    Rastija, Vesna
    Molnar, Maja
    PHARMACEUTICALS, 2020, 13 (07) : 1 - 21
  • [36] New Bioactive Dipiperazine Derivatives; Synthesis, Molecular Docking and Urease Inhibition Study
    Moghadam, Ebrahim Saeedian
    Al-Sadi, Abdullah Mohammed
    Talebi, Meysam
    Amanlou, Massoud
    Amini, Mohsen
    Abdel-Jalil, Raid
    CHEMISTRYSELECT, 2023, 8 (17):
  • [37] Inhibition of iNOS by Benzimidazole Derivatives: Synthesis, Docking, and Biological Evaluations
    Minhas, Richa
    Bansal, Yogita
    MEDICINAL CHEMISTRY, 2022, 18 (05) : 602 - 615
  • [38] Synthesis, in vitro α-amylase, α-glucosidase activities and molecular docking study of new benzimidazole bearing thiazolidinone derivatives
    Khan, Shoaib
    Ullah, Hayat
    Rahim, Fazal
    Nawaz, Mohsan
    Hussain, Rafaqat
    Rasheed, Liaqat
    JOURNAL OF MOLECULAR STRUCTURE, 2022, 1269
  • [39] Design, Synthesis, In Vitro Antimicrobial, Antioxidant Evaluation, and Molecular Docking Study of Novel Benzimidazole and Benzoxazole Derivatives
    Kashid, Bharat B.
    Ghanwat, Anil A.
    Khedkar, Vijay M.
    Dongare, Balasaheb B.
    Shaikh, Mubarak H.
    Deshpande, Prathmesh P.
    Wakchaure, Yogesh B.
    JOURNAL OF HETEROCYCLIC CHEMISTRY, 2019, 56 (03) : 895 - 908
  • [40] In silico molecular docking study, synthesis and α-amylase inhibitory activity evaluation of phosphorylated derivatives of purine
    Pavan Phani Kumar, M.
    Anuradha, V.
    Subramanyam, Ch.
    Hari Babu, V. V.
    PHOSPHORUS SULFUR AND SILICON AND THE RELATED ELEMENTS, 2021, 196 (11) : 1010 - 1017